Our findings revealed that patients with AR‐NHL with elevated histological expression of PD‐1 also exhibit elevated PD‐1 levels in peripheral blood Tregs, which serves as a supplementary predictor of an inferior prognosis. The gene discussed is PDCD1; the disease is non-Hodgkin lymphoma.